Russian government ready for massive procurements of HIV drugs

The Russian government will consider the allocation up to 48 billion roubles ($625 million) in public procurements of anti-HIV drugs this year, The Pharma Letter’s local correspondent reports.

This could be in response to the recent calls of experts of Patient Control movement (a public association in Russia, which represents the interests of patients) to the government and the State Duma, to fully cover treatment of people who are affected by HIV in Russia.

Earlier, representatives of the Russian Ministry of Health said that the share of HIV patients who receive therapy in Russia is constantly growing although the problem still exists.